Cargando…
Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells
The identification of arsenic direct-binding proteins is essential for determining the mechanism by which arsenic trioxide achieves its chemotherapeutic effects. At least two cysteines close together in the amino acid sequence are crucial to the binding of arsenic and essential to the identification...
Autores principales: | Zhang, Tao, Lu, Haojie, Li, Weijun, Hu, Ronggui, Chen, Zi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661853/ https://www.ncbi.nlm.nih.gov/pubmed/26569224 http://dx.doi.org/10.3390/ijms161125994 |
Ejemplares similares
-
The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
por: Chin, Lynn, et al.
Publicado: (2022) -
Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
por: Fouzia, N. A., et al.
Publicado: (2020) -
Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
por: Kumana, Cyrus R., et al.
Publicado: (2022) -
Recent advances in acute promyelocytic leukaemia
por: Ng, Chin-Hin, et al.
Publicado: (2017) -
Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)